Graft Versus Host Disease

Showing 51 - 75 of 178

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

GVHD, Leukemia, Lymphoma Trial in Buffalo (biological, drug, procedure, radiation)

Completed
  • Graft Versus Host Disease
  • +4 more
  • anti-thymocyte globulin
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Nov 25, 2019

Blood Cancer, Leukemia, GVHD Trial in Stanford (non-myeloablative hematopoietic cell transplantation, Anti-Thymocyte Globulin,

Completed
  • Blood Cancer
  • +7 more
  • non-myeloablative hematopoietic cell transplantation
  • +8 more
  • Stanford, California
    Stanford University School of Medicine
Nov 17, 2019

GVHD Trial in United States (RGI-2001, Calcineurin Inhibitors, Allogeneic Hematopoietic Stem Cell Transplantation)

Completed
  • Graft Versus Host Disease
  • San Diego, California
  • +5 more
Oct 15, 2019

Hematopoietic Cell Transplantation (HCT)

Completed
  • Allogeneic Stem Cell Transplant
  • +3 more
    • (no location specified)
    Sep 26, 2019

    Second-Line Therapy in Acute Graft-Versus-Host Study Including

    Terminated
    • Graft Versus Host Disease
    • medical chart review
    • quality-of-life assessment
    • Scottsdale, Arizona
    • +6 more
    Oct 14, 2019

    Anemia, GVHD, Leukemia Trial in Baltimore (biological, drug, procedure, radiation)

    Completed
    • Anemia
    • +5 more
    • anti-thymocyte globulin
    • +6 more
    • Baltimore, Maryland
      Marlene & Stewart Greenebaum Cancer Center, University of Maryla
    Oct 15, 2019

    GVHD Trial in Nantes (Probe based confocal laser endomicroscopy (Cellvizio))

    Completed
    • Graft Versus Host Disease
    • Probe based confocal laser endomicroscopy (Cellvizio)
    • Nantes, France
      CORON Emmanuel
    Aug 28, 2019

    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, GVHD Trial in Australia,

    Completed
    • B-cell Childhood Acute Lymphoblastic Leukemia
    • +5 more
    • Phoenix, Arizona
    • +49 more
    Jul 24, 2019

    GVHD Trial in United States (Ibrutinib)

    Completed
    • Graft Versus Host Disease
    • Duarte, California
    • +9 more
    Jun 14, 2019

    GVHD Trial in Belgium, France (Imatinib Mesylate and Nilotinib)

    Completed
    • Graft Versus Host Disease
    • Imatinib Mesylate and Nilotinib
    • Liège, Belgium
    • +21 more
    Jul 9, 2019

    GVHD, Steroid Refractory GVHD, Acute GVH Disease Trial in Gainesville, Columbus, San Antonio (Infliximab and Basiliximab)

    Terminated
    • Graft Versus Host Disease
    • +2 more
    • Infliximab and Basiliximab
    • Gainesville, Florida
    • +2 more
    Apr 3, 2019

    Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Detroit (biological, drug, other, procedure)

    Terminated
    • Chronic Myeloproliferative Disorders
    • +7 more
    • anti-thymocyte globulin
    • +7 more
    • Detroit, Michigan
      Karmanos Cancer Institute
    Mar 13, 2019

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Terminated
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +110 more
    • Omaha, Nebraska
      University of Nebraska Medical Center
    Feb 6, 2019

    GVHD, Leukemia, Lymphoma Trial in United Kingdom (CD4 DLI, No DLI)

    Unknown status
    • Graft Versus Host Disease
    • +4 more
    • CD4 DLI
    • No DLI
    • Birmingham, United Kingdom
    • +10 more
    Feb 11, 2019

    Bone Marrow Transplant Complications, GVHD, Infection Viral Trial in São Paulo (Cyclophosphamide, ATG)

    Recruiting
    • Bone Marrow Transplant Complications
    • +4 more
    • São Paulo, SP, Brazil
      Hospita Israelita Albert Eintein
    Jan 31, 2019

    Gut Microbiota, Inflammation and Symptoms Following Allogeneic

    Completed
    • Graft vs Host Disease
    • +3 more
    • Questionnaires
    • +3 more
    • Gainesville, Florida
      UF Health Cancer Hospital
    Jan 23, 2019

    GVHD Trial in Winston-Salem (total nodal irradiation, laboratory biomarker analysis, questionnaire administration)

    Terminated
    • Graft Versus Host Disease
    • total nodal irradiation
    • +2 more
    • Winston-Salem, North Carolina
      Comprehensive Cancer Center of Wake Forest University
    Oct 24, 2018

    GVHD, Hyperkalemia, Craniectomy Trial in Phoenix (Irradiated Blood Transfusions, Non-Irradiated Blood Transfusions)

    Completed
    • Graft Versus Host Disease
    • +5 more
    • Irradiated Blood Transfusions
    • Non-Irradiated Blood Transfusions
    • Phoenix, Arizona
      Phoenix Children's Hospital
    Oct 17, 2018

    GVHD Trial in Baltimore (Cyclophosphamide)

    Completed
    • Graft Versus Host Disease
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Sep 11, 2018

    GVHD, Stem Cell Transplantation Trial in Durham (voriconazole)

    Completed
    • Graft Versus Host Disease
    • Stem Cell Transplantation
    • Durham, North Carolina
      Duke University Medical Center
    Aug 31, 2018

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +117 more
    • Ann Arbor, Michigan
      University of Michigan University Hospital
    Jun 28, 2018

    GVHD Trial in Houston (Photopheresis, Methylprednisolone)

    Completed
    • Graft Versus Host Disease
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    May 3, 2018

    Acute Leukemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Atlanta (Thymoglobulin,

    Terminated
    • Acute Leukemia
    • +11 more
    • Thymoglobulin
    • +2 more
    • Atlanta, Georgia
      Emory University/Winship Cancer Institute
    Mar 30, 2018

    GVHD, Leukemia, Lymphoma Trial (biological, drug, genetic, other, procedure)

    Completed
    • Graft Versus Host Disease
    • +6 more
    • anti-thymocyte globulin
    • +13 more
    • (no location specified)
    Mar 5, 2018

    GVHD Trial in Boston (LDE225)

    Terminated
    • Graft Versus Host Disease
    • Boston, Massachusetts
    • +2 more
    Mar 15, 2018